Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;36(1):53-67.
doi: 10.1016/j.cger.2019.09.002. Epub 2019 Sep 6.

Orthostatic Hypotension in Parkinson Disease

Affiliations
Review

Orthostatic Hypotension in Parkinson Disease

Jose-Alberto Palma et al. Clin Geriatr Med. 2020 Feb.

Abstract

Orthostatic hypotension (OH) is a sustained fall in blood pressure on standing that can cause symptoms of organ hypoperfusion. OH is associated with increased morbidity and mortality and leads to a significant number of hospital admissions. OH can be caused by volume depletion, blood loss, cardiac pump failure, large varicose veins, medications, or defective activation of sympathetic nerves and reduced norepinephrine release upon standing. Neurogenic OH is a frequent and disabling problem in patients with synucleinopathies such as Parkinson disease, multiple system atrophy, and pure autonomic failure, and it is commonly associated with supine hypertension. Several therapeutic options are available.

Keywords: Autonomic failure; Baroreflex dysfunction; Droxidopa; Midodrine; Neurogenic orthostatic hypotension; Norepinephrine.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Neurotransmitter disorders in Parkinson disease.
Neurogenic orthostatic hypotension can be understood as a neurotransmitter disorder, similar to the motor dysfunction. Nigrostriatal dopaminergic denervation causing defective dopamine (DA) release results in the movement disorder, whereas postganglionic sympathetic denervation causing defective norepinephrine (NE) release when standing causes neurogenic orthostatic hypotension.

References

    1. Woerman AL, Stohr J, Aoyagi A, et al. Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci USA 2015; 11:E4949–58. - PMC - PubMed
    1. Masuda-Suzukake M, Nonaka T, Hosokawa M, et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 2013;136:1128–38. - PMC - PubMed
    1. Prusiner SB, Woerman AL, Mordes DA, et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 2015; 112:E5308–5317. - PMC - PubMed
    1. Peelaerts W, Bousset L, Van der Perren A, et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 2015;522:340–4. - PubMed
    1. Peelaerts W, Baekelandt V. a-Synuclein strains and the variable pathologies of synucleinopathies. J Neurochem 2016; 139 Suppl 1:256–74. - PubMed

Publication types

MeSH terms